Cyclosporine A increases angiotensin-converting enzyme activity in heart transplant patients.
Andert
S E
SE
Second Department of Surgery, University of Vienna, Austria.
Feichtinger
E
E
Grabenwöger
M
M
Grimm
M
M
Schreiner
W
W
Müller
M M
MM
D000595:Amino Acid Sequence; D001379:Azathioprine / Q000627:therapeutic use; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D005260:Female; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology*; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000378:metabolism; D007703:Peptidyl-Dipeptidase A / Q000097:blood*; D013256:Steroids / Q000627:therapeutic use; D013379:Substrate Specificity; D013997:Time Factors; D014471:Umbilical Veins
D009842:Oligopeptides; D013256:Steroids; D016572:Cyclosporine; D003404:Creatinine; D007703:Peptidyl-Dipeptidase A; D001379:Azathioprine